Seattle Biotech Giant Sana Pulls Plug on Bothell Manufacturing, Records $44.6MM Facility Loss

Biotech company writes down facilities amid shift to outsourced production and mounting losses Sana Biotechnology recorded a $44.6 million impairment charge in the second quarter as the cell therapy developer abandoned plans for internal manufacturing, highlighting the financial strain facing the Seattle-based company as it burns through cash while advancing experimental treatments. The non-cash write-down […]